carbachol has been researched along with Liver Neoplasms in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elouaer-Blanc, L | 1 |
| Sobhani, I | 1 |
| Ruszniewski, P | 1 |
| Duet, M | 1 |
| Lehy, T | 1 |
| Mignon, M | 1 |
| Bonfils, S | 1 |
| Lewin, MJ | 1 |
1 other study available for carbachol and Liver Neoplasms
| Article | Year |
|---|---|
Gastrin secretion by gastrinoma cells in long-term culture.
Topics: Bombesin; Bucladesine; Calcimycin; Calcium; Carbachol; Culture Media; Gastrinoma; Gastrins; Humans; | 1988 |